Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease

Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease

BackgroundSarcopenia is known to be the risk factor of non-alcoholic fatty liver disease (NAFLD). However, studies evaluating the association of skeletal muscle mass (SMM) with liver fibrosis by transient elastography are limited. Here, we investigated the association of SMM with hepatic steatosis a...

Full description

Bibliographic Details
Main Authors:	Wen Guo, Xin Zhao, Mengyuan Miao, Xiuru Liang, Xiaona Li, Pei Qin, Jing Lu, Wenfang Zhu, Juan Wu, Chen Zhu, Nianzhen Xu, Qun Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Nutrition
Subjects:	skeletal muscle mass hepatic steatosis liver fibrosis non-alcoholic fatty liver disease skeletal muscle mass index
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2022.883015/full

Similar Items

Differences among Three Skeletal Muscle Mass Indices in Predicting Non-Alcoholic Fatty Liver Disease: Korean Nationwide Population-Based Study
by: A-Ra Cho, et al.
Published: (2021-07-01)

The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes
by: Xiaoyou Su, et al.
Published: (2019-07-01)

Association of Low Skeletal Muscle Mass with the Phenotype of Lean Non-Alcoholic Fatty Liver Disease
by: Jun-Hyeon Byeon, et al.
Published: (2022-05-01)

The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults
by: Wen Guo, et al.
Published: (2020-10-01)

Relative Skeletal Muscle Mass Is an Important Factor in Non-Alcoholic Fatty Liver Disease in Non-Obese Children and Adolescents
by: Yoowon Kwon, et al.
Published: (2020-10-01)

Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease
by: Shida T, et al.
Published: (2019-04-01)

Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease
by: Jun-Hyuk Lee, et al.
Published: (2021-02-01)

Reference Values for Skeletal Muscle Mass – Current Concepts and Methodological Considerations
by: Carina O. Walowski, et al.
Published: (2020-03-01)

High intensity interval exercise alters muscle IL-18, FNDC5, and hepatic MMPs in animal model of steatosis: Evidence of skeletal muscle—liver crosstalk
by: Mahmoud Delphan, et al.
Published: (2021-12-01)

Radiological assessment of skeletal muscle index and myosteatosis and their impact postoperative outcomes after liver transplantation
by: Petric Miha, et al.
Published: (2023-06-01)

Appendicular skeletal muscle mass assessment in dogs: a scoping literature review
by: Ah Young Kim, et al.
Published: (2022-07-01)

Appendicular Skeletal Muscle Index and HbA1c Evaluate Liver Steatosis in Patients With Metabolic Associated Fatty Liver Disease
by: Rui Jin, et al.
Published: (2022-07-01)

Episodic Binge-like Ethanol Reduces Skeletal Muscle Strength Associated with Atrophy, Fibrosis, and Inflammation in Young Rats
by: Constanza Cáceres-Ayala, et al.
Published: (2023-01-01)

Probiotics as Potential Therapeutic Agents: Safeguarding Skeletal Muscle against Alcohol-Induced Damage through the Gut–Liver–Muscle Axis
by: Martina Sausa, et al.
Published: (2024-02-01)

Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans
by: Yasuyuki Tamai, et al.
Published: (2022-10-01)

Association between Osteoporosis and Skeletal Muscle Mass in Men
by: Masaya Mizutani, et al.
Published: (2024-02-01)

The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease
by: Jun Sung Moon, et al.
Published: (2013-08-01)

Impact of Preoperative Skeletal Muscle Mass and Quality on the Survival of Elderly Patients After Curative Resection of Colorectal Cancer
by: Yasutomo Ojima, et al.
Published: (2019-10-01)

Improvement of Diagnostic Algorithm in Patients With Alcoholic Fatty Liver Disease by Using Non-invasive Methods of Verification of Liver Steatosis and Fibrosis
by: Svintsitskyy A., et al.
Published: (2016-07-01)

Relationship between body composition and the histology of non‐alcoholic fatty liver disease: a cross‐sectional study
by: Teruki Miyake, et al.
Published: (2021-04-01)

Chronic alcohol ingestion delays skeletal muscle regeneration following injury
by: Dekeyser Graham J, et al.
Published: (2013-01-01)

Meeting Synopsis:Advances in Skeletal Muscle Biology in Health and DiseaseGainesville, FloridaFebruary 22nd to 24th 2012Day 1: Cell signaling mechanisms mediating muscle atrophy and hypertrophy and Muscle force, calcium handling, and stress response
by: Andrew R Judge, et al.
Published: (2012-06-01)

Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography
by: Hwi Seung Kim, et al.
Published: (2023-01-01)

The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers
by: Zahra Safari, et al.
Published: (2023-05-01)

Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver
by: Min-Kyu Kang, et al.
Published: (2021-06-01)

Impact of Alcohol on Glycemic Control and Insulin Action
by: Jennifer L. Steiner, et al.
Published: (2015-09-01)

Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A Prospective, Randomized, Controlled Pilot Trial
by: Tomomi Okubo, et al.
Published: (2021-05-01)

Impact of Skeletal Muscle Mass on Metabolic Health
by: Gyuri Kim, et al.
Published: (2020-03-01)

Mitochondrial Dysfunction: At the Nexus between Alcohol-Associated Immunometabolic Dysregulation and Tissue Injury
by: Robert W. Siggins, et al.
Published: (2023-05-01)

Isometric skeletal muscle contractile properties in common strains of male laboratory mice
by: Everett C. Minchew, et al.
Published: (2022-10-01)

Impact of Mitophagy and Mitochondrial Unfolded Protein Response as New Adaptive Mechanisms Underlying Old Pathologies: Sarcopenia and Non-Alcoholic Fatty Liver Disease
by: Rodrigo Urbina-Varela, et al.
Published: (2020-10-01)

The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population
by: Hirsh D. Trivedi, et al.
Published: (2021-09-01)

Preoperative Assessment of Skeletal Muscle Mass and Muscle Quality Using Computed Tomography: Incidence of Sarcopenia in Patients with Intrahepatic Cholangiocarcinoma Selected for Liver Resection
by: Francesco Ardito, et al.
Published: (2022-03-01)

Muscle Mass Adjusted for Body Weight Is Associated with Significant Liver Fibrosis in Young Adults with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Korean Military Hospital
by: Jaejun Lee, et al.
Published: (2023-09-01)

Sex- and region-specific associations of skeletal muscle mass with metabolic dysfunction-associated fatty liver disease
by: Pei Xiao, et al.
Published: (2022-12-01)

Multiple molecular targets in the liver, adipose tissue and skeletal muscle in ginger-elicited amelioration of nonalcoholic fatty liver disease
by: Chunxia Wang, et al.
Published: (2017-09-01)

Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
by: Berend R. Beumer, et al.
Published: (2022-10-01)

Aging‐related hyperphosphatemia impairs myogenic differentiation and enhances fibrosis in skeletal muscle
by: Patricia Sosa, et al.
Published: (2021-10-01)

Role of Myokines in Regulating Skeletal Muscle Mass and Function
by: Jong Han Lee, et al.
Published: (2019-01-01)

Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil
by: Tomoyuki Matsunaga, et al.
Published: (2021-11-01)